Prediction of disability-free survival in healthy older people
Access Status
Authors
Date
2022Type
Metadata
Show full item recordCitation
Source Title
ISSN
Faculty
School
Funding and Sponsorship
Collection
Abstract
Prolonging survival in good health is a fundamental societal goal. However, the leading determinants of disability-free survival in healthy older people have not been well established. Data from ASPREE, a bi-national placebo-controlled trial of aspirin with 4.7 years median follow-up, was analysed. At enrolment, participants were healthy and without prior cardiovascular events, dementia or persistent physical disability. Disability-free survival outcome was defined as absence of dementia, persistent disability or death. Selection of potential predictors from amongst 25 biomedical, psychosocial and lifestyle variables including recognized geriatric risk factors, utilizing a machine-learning approach. Separate models were developed for men and women. The selected predictors were evaluated in a multivariable Cox proportional hazards model and validated internally by bootstrapping. We included 19,114 Australian and US participants aged ≥65 years (median 74 years, IQR 71.6–77.7). Common predictors of a worse prognosis in both sexes included higher age, lower Modified Mini-Mental State Examination score, lower gait speed, lower grip strength and abnormal (low or elevated) body mass index. Additional risk factors for men included current smoking, and abnormal eGFR. In women, diabetes and depression were additional predictors. The biased-corrected areas under the receiver operating characteristic curves for the final prognostic models at 5 years were 0.72 for men and 0.75 for women. Final models showed good calibration between the observed and predicted risks. We developed a prediction model in which age, cognitive function and gait speed were the strongest predictors of disability-free survival in healthy older people. Trial registration Clinicaltrials.gov (NCT01038583).
Related items
Showing items related by title, author, creator and subject.
-
Roebuck, G.; Lotfaliany, M.; Agustini, B.; Forbes, M.; Mohebbi, M.; McNeil, J.; Woods, R.L.; Reid, Christopher ; Nelson, M.R.; Shah, R.C.; Ryan, J.; Newman, A.B.; Owen, A.; Freak-Poli, R.; Stocks, N.; Berk, M. (2023)Background: Gerontology and ageing research are increasingly focussing on healthy life span (healthspan), the period of life lived free of serious disease and disability. Late-life depression (LLD) is believed to impact ...
-
Zhou, Z.; Ofori-Asenso, R.; Curtis, A.J.; Breslin, M.; Wolfe, R.; McNeil, J.J.; Murray, A.M.; Ernst, M.E.; Reid, Christopher ; Lockery, J.E.; Woods, R.L.; Tonkin, A.M.; Nelson, M.R. (2020)© 2020 American College of Cardiology Foundation Background: There is clinical uncertainty regarding the benefits and harms of prescribing statins in healthy subjects ≥70 years of age. Objectives: The aim of this study ...
-
McNeil, J.; Woods, R.; Nelson, M.; Reid, Christopher; Kirpach, B.; Wolfe, R.; Storey, E.; Shah, R.; Lockery, J.; Tonkin, A.; Newman, A.; Williamson, J.; Margolis, K.; Ernst, M.; Abhayaratna, W.; Stocks, N.; Fitzgerald, S.; Orchard, S.; Trevaks, R.; Beilin, L.; Donnan, G.; Gibbs, P.; Johnston, C.; Ryan, J.; Radziszewska, B.; Grimm, R.; Murray, A. (2018)Background: Information on the use of aspirin to increase healthy independent life span in older persons is limited. Whether 5 years of daily low-dose aspirin therapy would extend disabilityfree life in healthy seniors ...